Making invisible cancers visible: A new route to turn 'cold' tumors 'hot'

Дата публикации: 17-09-2026 17:40:17

One of the biggest challenges in cancer immunotherapy may not be that immune cells are too weak, but that some tumors give them too little to see. New research from Dana-Farber Cancer Institute scientists reveals how cancers carrying mutations in the p53 tumor-suppressor protein can hide those mutations from T cells and suggests a therapeutic countermeasure: Change what the cancer displays on its surface so the immune system can recognize the tumor.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Study identifies potential RAS inhibitor-immunotherapy strategy for pancreatic cancer	0	7.48	23-09-2026
2	Researchers find secret protein that drives cancer cell division	0	6.17	25-09-2026
3	Science & Medicine: Studying the 'form and function' of prostate cancer's main driver leads to a breakthrough	0	5.98	20-09-2026
4	A blood-based approach could enable personalized immunotherapy without the need for a tumor biopsy	0	10.91	29-09-2026
5	Cancer biologists bring in the B-cell reinforcements for immunotherapy	0	8.93	17-09-2026
6	Metabolic activity of gut bacteria can either promote or inhibit function of CAR T cells in cancer therapy	0	6.96	28-09-2026
7	'Plug-and-play' CAR T technology adapts as cancer changes	0	8.18	22-09-2026
8	How missing pieces of the Y chromosome drive cancer in men	0	8.84	28-09-2026
9	Protein modification network plays vital role in cancer development	0	6.81	24-09-2026
10	Scientists reveal what damages the DNA in most prostate cancers	0	9	10-09-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.83. Источник: medicalxpress.com.